Neurotech International Ltd (NTI) - Total Liabilities

Latest as of December 2025: AU$932.85K AUD ≈ $660.05K USD

Based on the latest financial reports, Neurotech International Ltd (NTI) has total liabilities worth AU$932.85K AUD (≈ $660.05K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore NTI net assets growth trend to track the company's year-over-year net asset growth rate.

Neurotech International Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Neurotech International Ltd's total liabilities have evolved over time, based on quarterly financial data.

Neurotech International Ltd Competitors by Total Liabilities

The table below lists competitors of Neurotech International Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
HPMT Holdings Bhd KLSE:5291	Malaysia	RM27.61 Million
Crown Lifters Limited NSE:CROWN	India	Rs1.19 Billion
Lifestyle Global Enterprise TWO:8066	Taiwan	NT$901.60 Million
Talius Group Ltd. AU:TAL	Australia	AU$1.19 Million
SAGTEC GLOBAL LIMITED Ordinary shares NASDAQ:SAGT	USA	$14.64 Million
Les Hôtels de Paris SA PA:HDP	France	€236.82 Million
Peak Processing Limited AU:PKP	Australia	AU$18.75 Million
Natural Alternatives International NASDAQ:NAII	USA	$86.25 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Neurotech International Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Neurotech International Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.30	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.16	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.14	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neurotech International Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neurotech International Ltd (2015–2025)

The table below shows the annual total liabilities of Neurotech International Ltd from 2015 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$285.74K ≈ $202.18K	-9.20%
2024-06-30	AU$314.70K ≈ $222.67K	-76.63%
2023-06-30	AU$1.35 Million ≈ $952.99K	+127.14%
2022-06-30	AU$592.98K ≈ $419.57K	-48.19%
2021-06-30	AU$1.14 Million ≈ $809.75K	+57.40%
2020-06-30	AU$727.10K ≈ $514.47K	+104.62%
2019-06-30	AU$355.33K ≈ $251.42K	-5.41%
2018-06-30	AU$375.66K ≈ $265.80K	-42.83%
2017-06-30	AU$657.04K ≈ $464.90K	-26.43%
2016-06-30	AU$893.12K ≈ $631.94K	-55.08%
2015-12-31	AU$1.99 Million ≈ $1.41 Million	--

About Neurotech International Ltd

AU:NTI Australia Biotechnology

Market Cap

$13.99 Million

AU$19.77 Million AUD

Market Cap Rank

#26170 Global

#1179 in Australia

Share Price

AU$0.02

Change (1 day)

-11.76%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$0.48